Lab2Launch

A launch pad for innovation and entrepreneurship

Apply to Lab2Launch

The programming & infrastructure built for you

As part of Emory School of Medicine’s commitment to advancing biomedical innovation and entrepreneurship, Lab2Launch is designed to provide flexible and low-cost co-working and wet laboratory space to Emory-affiliated start-up companies developing promising technologies that improve patient health.

Lab2Launch provides capital-efficient access to a well-rounded laboratory infrastructure, removing barriers for innovative scientist-entrepreneurs to launch and grow new ventures and generate the proof-of-concept they need to expand their technology and team.

Lab2Launch residents will also be able to leverage the network, and rich business development and technical programming provided by Biolocity - a sister program, that funds and assists promising early-stage teams through consultation and project management in their commercialization journey.

Eligibility

Company selection will be based on the following affiliations with Emory University:

  • Emory researchers (e.g., faculty, staff, post-docs)
  • Outside companies that hold license(s) to and are commercializing Emory IP

The benefits of joining the Lab2Launch Community

Available lab spaces

  • 48 lab bench workstations in an open Biosafety level 2 lab
  • 6 flexible and shared procedure rooms
  • 3 Novel Technology private suites (ranging from 400 to 700 sq.ft.)
  • 2 main shared equipment corridors outfitted with a cold room
  • 1 fume hood alcove

Lab Equipment

  • Cold storage: -80C, -20C, +4C
  • Glassware prep: autoclave, glass washer
  • Formulation: water purification system, balance, pH meter
  • General lab equipment: shaker incubator, biosafety cabinet, centrifuges, micropipettes, inverted microscope
  • Sample analysis: spectrophotometer, protein and DNA gel imager, gel apparatus

Lab2Launch is strategically located in the vicinity of various core facilities and resources within Emory, including a biorepository, vivarium, and flow cytometry core.

Built for you

Amenities

  • 22 dedicated desks in a shared workstations area
  • Kaldi’s Café
  • Shared breakroom
  • Bike storage room
  • Commuter shower facilities
  • Lactation rooms
  • Outdoor plaza with seating

Biolocity Programming

Lab2Launch residents will also be able to leverage the network, and rich business development and technical programming provided by Biolocity - a sister program, that funds and assists promising early stage teams through consultation and project management in their commercialization journey. In addition to procuring a state-of-the-art laboratory, we support your R&D goals by facilitating improved access to:

  • Legal office hours
  • Educational resources
  • Business development and technical programming
  • Networking events

Application process

Application Timeline:

Applications are on a rolling basis. If accepted after evaluation, company onboarding and move-in can take up to two (2) months. 

Application Documents:

  • Current business plan and/or non-confidential pitch deck
  • Financial statements including balance sheet and income statement
  • Statement of ownership of company
  • Names of members of board of directors (or board of advisors) and short bios

Residency Contingencies:

  • Faculty associated with applicant companies must complete all Emory University intellectual property and conflict of interest disclosures and approvals.
  • Company will enter into a Space Use License Agreement with Emory.
    • Company must maintain liability insurance as described in the Space Use License Agreement.
  • Company must comply with all local, state, and federal laws and regulations as well as Emory University policies and procedures regarding environmental health and safety (EHS).
  • Company will participate in annual progress review process.


Health Sciences Research Building II Innovation Floor

"In my experience, you need to create new companies to take scientific discoveries from the laboratory to the clinic. These highly-focused, entrepreneurial enterprises can move more quickly and more cheaply from discovery to development than larger, more complex pharmaceutical companies. I believe that the modern tools and extensive resources available through the Innovation Floor will accelerate the ability of start-up companies to transform laboratory discoveries into drugs that prevent, treat and, ultimately, cure life-threatening diseases."

Raymond F. Schinazi